2025 ASCO Poster: Cell-free circulating chromatin profiles enable epigenomic characterization of mechanisms of response and resistance to sacituzumab govitecan in breast cancer

‍

We use cookies to provide the content and functionality of this website, and subject to your consent, to analyze the use of our website and to ensure you get the best experience. Third parties with whom we collaborate can also install cookies in order to show you personalized advertisements on other websites. Read our cookie notice for more information

ACCEPT All REJECT ALL MANAGE MY SETTINGS